FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to therapy, and concerns treating infectious diseases caused by an influenza virus with type H5N1 surface antigen. That is ensured by administering a therapeutic agent containing a homeopathic activated potentiated form of the human gamma-interferon antibodies prepared of a matrix solution of affine purified human gamma-interferon antibodies in the concentration of 0.3-5.0 mg/ml.
EFFECT: higher clinical effectiveness in the infectious diseases.
8 cl, 2 ex, 2 tbl
Authors
Dates
2013-12-10—Published
2010-02-27—Filed